Professor Michael Loebinger is a consultant respiratory physician who treats private and NHS patients at Royal Brompton and Harefield hospitals. He leads the respiratory infection service.
He studied at the University of Cambridge where he obtained a first class degree in Medical Sciences. He then moved to the University of Oxford where he completed his clinical training. Following that, he trained in respiratory medicine in London, at a number of hospitals including St Thomas’, Hammersmith, Charing Cross, St Mary’s, and Royal Brompton hospitals.
Professor Loebinger has won prestigious awards from the Royal Society of Medicine, the European Respiratory Society, the British Thoracic Society, the American Thoracic Society, the Medical Research Society, the British Lung Foundation and the British Association of Lung Research. He was also awarded Professor of practice at Imperial College London.
Professor Michael Loebinger is a respiratory consultant and clinical lead for respiratory infections. These include patients with:
- host defence abnormalities
- primary ciliary dyskinesia
- primary immunodeficiency
- non-tuberculosis mycobacterial infections
- fungal disease
He is chair of the European Respiratory Society (ERS) Infection Group and previously chaired the British Thoracic Society (BTS) Infection Special Advisory Group and the national British Thoracic Society guidelines for bronchiectasis. He also co-wrote the BTS nontuberculous mycobacteria and ERS bronchiectasis guidelines.
In 2006, Professor Michael Loebinger was awarded a Clinical Research Training Fellowship from the Medical Research Council for research into the use of adult stem cells in lung disease. This research was performed at UCL and led to a PhD, multiple publications and awards and significant media interest.
His current research aims focus on chronic lung infections. He is currently researching host susceptibility to these infections, in addition to the development of biomarkers and clinical endpoints to assist in their management. He has helped set up national and European research networks, with funding to produce clinical bronchiectasis databases and is the recipient of several prestigious research grants. He also collaborates with industry and is the principal investigator of multicentre international clinical trials.
Professor Michael Loebinger is a professor of practice at Imperial College London. He supervises PhD and MSc students. He accepts multiple medical students for research attachments each year. He has been an Imperial College tutor and is an Imperial College assessor for higher degrees.